دورية أكاديمية

Post-COVID-19 respiratory sequelae two years after hospitalization: an ambidirectional study.

التفاصيل البيبلوغرافية
العنوان: Post-COVID-19 respiratory sequelae two years after hospitalization: an ambidirectional study.
المؤلفون: Ribeiro Carvalho CR; Division of Pulmonary Medicine, Heart Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Lamas CA; Division of Pulmonary Medicine, Heart Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Visani de Luna LA; Division of Pulmonary Medicine, Heart Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Chate RC; Radiology Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Salge JM; Division of Pulmonary Medicine, Heart Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Yamada Sawamura MV; Radiology Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Toufen C; Division of Pulmonary Medicine, Heart Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Garcia ML; Division of Pulmonary Medicine, Heart Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Scudeller PG; Division of Pulmonary Medicine, Heart Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Nomura CH; Radiology Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Gutierrez MA; Division of Informatics, Heart Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Baldi BG; Division of Pulmonary Medicine, Heart Institute, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
مؤلفون مشاركون: HCFMUSP Covid-19 Study Group
المصدر: Lancet regional health. Americas [Lancet Reg Health Am] 2024 Apr 17; Vol. 33, pp. 100733. Date of Electronic Publication: 2024 Apr 17 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918232503006676 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-193X (Electronic) Linking ISSN: 2667193X NLM ISO Abbreviation: Lancet Reg Health Am Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Oxford] : Elsevier Ltd., [2021]-
مستخلص: Background: COVID-19 lung sequelae can impact the course of patient lives. We investigated the evolution of pulmonary abnormalities in post-COVID-19 patients 18-24 months after hospital discharge.
Methods: A cohort of COVID-19 patients admitted to the Hospital das Clínicas da Faculdade de Medicina da USP in São Paulo, Brazil, between March and August of 2020, were followed-up 6-12 months after hospital discharge. A subset of patients with pulmonary involvement and chest computed tomography (CT) scans were eligible to participate in this second follow-up (18-24 months). Data was analyzed in an ambidirectional manner, including retrospective data from the hospitalization, and from the first follow-up (6-12 months after discharge), and compared with the prospective data collected in this new follow-up.
Findings: From 348 patients eligible, 237 (68%) participated in this follow-up. Among participants, 139 (58%) patients presented ground-glass opacities and reticulations, and 80 (33%) presented fibrotic-like lesions (traction bronchiectasis and architectural distortion). Five (2%) patients improved compared to the 6-12-month assessment, but 20 (25%) of 80 presented worsening of lung abnormalities. For those with relevant assessments on both occasions, comparing the CT findings between this follow-up with the previous assessment, there was an increase in patients with architectural distortion (43 [21%] of 204 vs 57 [28%] of 204, p = 0.0093), as well as in traction bronchiectasis (55 [27%] of 204 vs 69 [34%] of 204, p = 0.0043). Patients presented a persistent functional impairment with demonstrated restrictive pattern in both follow-ups (87 [42%] of 207 vs 91 [44%] of 207, p = 0.76), as well as for the reduced diffusion capacity (88 [42%] of 208 vs 87 [42%] of 208, p = 1.0). Length of hospitalization (OR 1.04 [1.01-1.07], p = 0.0040), invasive mechanical ventilation (OR 3.11 [1.3-7.5] p = 0.011), patient's age (OR 1.03 [1.01-1.06] p = 0.0074 were consistent predictors for development of fibrotic-like lung lesions in post-COVID-19 patients.
Interpretation: Post-COVID-19 lung sequelae can persist and progress after hospital discharge, suggesting airways involvement and formation of new fibrotic-like lesions, mainly in patients who were in intensive care unit (ICU).
Funding: São Paulo Research Foundation (22/01769-5) and Instituto Todos pela Saúde (C1721).
Competing Interests: We declare no competing interests.
(© 2024 The Authors.)
References: BMJ Open. 2021 Jun 30;11(6):e051706. (PMID: 34193506)
Arch Bronconeumol. 2023 Oct;59(10):691-697. (PMID: 37640655)
Emerg Microbes Infect. 2022 Dec;11(1):2680-2688. (PMID: 36215047)
Mol Psychiatry. 2023 Apr;28(4):1793-1801. (PMID: 36690792)
EClinicalMedicine. 2022 Sep 28;54:101668. (PMID: 36188433)
Radiology. 2023 Apr;307(2):e222888. (PMID: 36786698)
Clinics (Sao Paulo). 2011;66(6):933-7. (PMID: 21808854)
BMJ Open. 2022 Jun 13;12(6):e059110. (PMID: 35697456)
Respir Res. 2022 Sep 12;23(1):242. (PMID: 36096801)
Lancet Respir Med. 2022 Sep;10(9):863-876. (PMID: 35568052)
Front Immunol. 2022 Apr 20;13:865845. (PMID: 35529862)
Radiology. 2021 Apr;299(1):E177-E186. (PMID: 33497317)
Lancet Respir Med. 2023 Aug;11(8):739-754. (PMID: 37475125)
Lancet Respir Med. 2021 Jul;9(7):747-754. (PMID: 33964245)
BMJ. 2023 May 31;381:e074425. (PMID: 37257891)
Expert Rev Respir Med. 2021 Jun;15(6):791-803. (PMID: 33902377)
Radiology. 2022 Jul;304(1):185-192. (PMID: 35289657)
Eur J Intern Med. 2021 Oct;92:55-70. (PMID: 34167876)
Am Rev Respir Dis. 1991 Nov;144(5):1202-18. (PMID: 1952453)
Nat Immunol. 2022 Feb;23(2):194-202. (PMID: 35105985)
Braz J Med Biol Res. 1999 Jun;32(6):729-37. (PMID: 10412551)
PLoS One. 2023 Jan 20;18(1):e0280567. (PMID: 36662879)
Radiology. 2023 Apr;307(2):e222379. (PMID: 36692398)
Nat Med. 2023 Feb;29(2):334-343. (PMID: 36797482)
Respir Res. 2021 Jan 29;22(1):32. (PMID: 33514373)
Respir Res. 2020 Jun 29;21(1):163. (PMID: 32600344)
Lancet. 2021 Aug 28;398(10302):747-758. (PMID: 34454673)
Braz J Med Biol Res. 1999 Jun;32(6):703-17. (PMID: 10412549)
Nat Med. 2021 Apr;27(4):601-615. (PMID: 33753937)
J Bras Pneumol. 2007 Jul-Aug;33(4):397-406. (PMID: 17982531)
فهرسة مساهمة: Keywords: Ambidirectional cohort; COVID-19; Fibrosis; Lung CT; PASC; Pulmonary function; Small airways disease
تواريخ الأحداث: Date Created: 20240429 Latest Revision: 20240430
رمز التحديث: 20240430
مُعرف محوري في PubMed: PMC11047789
DOI: 10.1016/j.lana.2024.100733
PMID: 38680501
قاعدة البيانات: MEDLINE
الوصف
تدمد:2667-193X
DOI:10.1016/j.lana.2024.100733